Antibacterial fatty acid compositions

Patent 5434182 Issued on July 18, 1995. Estimated Expiration Date:

May 3, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Re32990

Urea derivatives to treat anxiety and aggressivity
Patent #: 4223041
Issued on: 09/16/1980
Inventor: Pigerol , et al.

Intravenous solutions with antimicrobial agent
Patent #: 4489097
Issued on: 12/18/1984
Inventor: Stone

Virucidal compositions and therapy
Patent #: 4513008
Issued on: 04/23/1985
Inventor: Revici , et al.

Inactivation of viruses in labile blood derivatives
Patent #: 4613501
Issued on: 09/23/1986
Inventor: Horowitz

Glutaric acid virucidal processes and compositions
Patent #: 4767788
Issued on: 08/30/1988
Inventor: Diana

Immunological lipid emulsion adjuvant
Patent #: 4806352
Issued on: 02/21/1989
Inventor: Cantrell

Virucidal product having virucidal and/or germicidal properties
Patent #: 4828912
Issued on: 05/09/1989
Inventor: Hossain , et al.

Inactivation of viruses in labile protein-containing compositions using fatty acids
Patent #: 4841023
Issued on: 06/20/1989
Inventor: Horowitz

Antimicrobial medical glove
Patent #: 4853978
Issued on: 08/08/1989
Inventor: Stockum

More ...

Inventors

Application

No. 058056 filed on 05/03/1993

US Classes:

514/546, ZC(=O)OY, wherein Z is an acyclic radical bonded to the C=O by a carbon and Y is an organic radical bonded to the oxygen by a carbon514/547, Compound contains two or more C(=O)O groups514/558Higher fatty acid or salt thereof

Examiners

Primary: Fay, Zohreh

Attorney, Agent or Firm

Kane, Dalsimer, Sullivan, Kurucz, Levy, Eisele and Richard

Foreign Patent References

21504 EP. 01/12/1981
0068552 EP. 01/12/1983
289204 EP. 11/12/1988
57-106618 JP. 07/12/1982
63-57549 JP. 03/12/1988
2181349 GB. 04/12/1987
8809655 WO. 12/12/1988

International Classes

A61K 031/22
A61K 031/225
A61K 031/20

Abstract

This invention is directed to antibacterial activity of fatty acids and monoglycerides. More particularly, this invention is directed to the killing of bacteria by fatty acids and monoglycerides. The invention is also directed to antibacterial pharmaceutical compositions consisting essentially of inert pharmaceutical carrier and an antibacterial effective amount of one or more compounds selected from the group consisting of fatty acids and monoglycerides thereof, fatty alcohols, and ethers and lysophosphatidylcholine derivatives.

Other References

Antimicrobial Agents and Chemotherapy, vol. 31, No. 1, Jan. 1987, pp. 27-31; H. Thormar et al
Journal of Dairy Science, vol. 59, No. 7, Jul. 1976, pp. 1203-1214, R. G. Jensen et al
Archives of Virology, vol. 66, 1980, pp. 301-307, Springer-Verlag; A. Kohn et al.: "Unsaturated free fatty acids inactivate animal enveloped viruses"
Microbios Letters, vol. 35, 1987, pp. 71-78, The Faculty Press, Cambridge, GB; V. A. Merchant et al.: "Unsaturated free fatty acid inhibition of herpes simplex virus"
Antimicrobial Agents and Chemotherapy, vol. 15, No. 1, Jan. 1979, pp. 67-73; J. Sands et al.: "Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols"
Antimicrobial Agents and Chemotherapy, vol. 18, No. 6, Dec. 1980, pp. 962-968; A. Kohn et al.: "Interaction of polyunsaturated fatty acids with animal cells and enveloped viruses"
Food Chem., vol. 4, No. 4, 1979, pp. 251-258, Applied Science Publishers Ltd. GB; G. Poli et al.: "Virucidal activity of organic acids"
Saheb et al., Chemical Abstracts, 90:67131v (1974)
Tsutsumi et al., Chemical Abstracts, 98:86086r (1983)
A. S. Cunningham, Morbidity in Breast-fed and Artificially Fed Infants, Journal of Pediatrics, 1979, vol. 95, No. 5, pp. 685-689
M. G. Meyers et al., Respiratory and Gastrointestinal Illnesses in Breast- and Formula-fed Infants, Am. J. Dis. Child, 1984, vol. 138, pp. 629-632
S. A. Larsen, Jr. et al., Relation of Breast versus Bottle Feeding to Hospitalization for Gastroenteritis in a Middle-class U.S. Population, Journal of Pediatrics, 1978 vol. 92, pp. 417-418
M. E. Fallot et al., Breast-feeding Reduces Incidence of Hospital Admissions for Infection in Infants, Pediatr., 1980, vol. 65, No. 6, pp. 1121-1124
A. S. Cunningham, Breast-feeding and Health, J. Pediatr., 1987, vol. 110, No. 4, pp. 658-659
G. A. Loslonsky et al., Maternal-Neonatal Interactions and Human Breast Milk in Reproductive Immunology, N. Gleicher (ed.), New York, Allan R. Riss, 1981, pp. 171-182
A. S. Goldman et al., Host Defenses: Development and Maternal Contributions, In: Advances in Pediatrics, L. A. Barnes (ed.), vol. 32, 1985, pp. 71-100
J. K. Welsh et al., Use of Semliki Forest virus to Identify Lipid-Mediated Antiviral Activity and Anti-Alphavirus Immunoglobulin A in Human Milk, Infect. Immun., 1978, vol. 19, No. 2, pp. 395-401
J. K. Welsh et al., Effect of Antiviral Lipids, Heat and Freezing on the Activity of Viruses in Human Milk, J. Infect. Dis., 1979, vol. 140, No. 3, pp. 322-328
C. E. Isaacs et al., Membrane-Disruptvie Effect of Human Milk: Inactivation of Enveloped viruses, J. Infect. Dis., 1986, vol. 154, No. 6, pp. 966-971
W. A. Falkler et al., A Lipid Inhibitor of Dengue Virus in Human Colostrum and Milk, Arch. Virol. 1975, vol. 47, pp. 3-10
A. H. Fieldsteel, Nonspecific Antiviral Substances in Human Milk Active against Arbovirus and Murine Leukemia Virus Cancer Res., 1974, vol. 34, pp. 712-715
T. H. Matthews et al., Antiviral Activity in Milk of Possible Clinical Importance, Lancet, 1976, vol. ii, pp. 1387-1389
Sarker et al., Effect of Human Milk on the Mouse Mammary Tumor Virus, Cancer Res., 1973, vol. 33, pp. 626-62